| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Radhakrishnan Karthik serves as a Chief Financial Officer at MNPR. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $185K at current prices.
The biggest single holding is MNPR (~$185K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 1,550 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | MNPR Monopar Therapeutics | Chief Financial Officer | Buy | 1,550 | $16.25 | $25,187.50 | New | +88.0% | +348.2% |